Coign Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$831K Sell
3,398
-776
-19% -$181K 0.44% 33
2025
Q4
$864K Buy
4,174
+63
+2% +$12.5K 0.45% 36
2025
Q3
$762K Buy
4,111
+87
+2% +$14.9K 0.42% 41
2025
Q2
$615K Buy
4,024
+76
+2% +$11.7K 0.42% 55
2025
Q1
$655K Sell
3,948
-174
-4% -$27.2K 0.5% 39
2024
Q4
$596K Buy
+4,122
New +$639K 0.55% 49

Other funds holding JNJ

Coign Capital Advisors's JNJ Position: Q1 2026 in Review

Coign Capital Advisors reduced its Johnson & Johnson (JNJ) stake by 19% in Q1 2026, selling an estimated $181K and leaving 3,398 shares worth $831K. The position accounts for 0.44% of the portfolio, ranked #33.

Coign Capital Advisors first reported a position in JNJ in Q4 2024 and has held it in 6 quarters since. The position peaked at $864K in Q4 2025. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Coign Capital Advisors held 3,398 shares of Johnson & Johnson worth $831K as of Q1 2026.
  • Coign Capital Advisors sold 776 Johnson & Johnson shares in Q1 2026, an estimated $181K.
  • Johnson & Johnson made up 0.44% of Coign Capital Advisors's portfolio in Q1 2026, its #33 holding.
  • Coign Capital Advisors first reported a position in Johnson & Johnson in Q4 2024 and has held it in 6 quarters since.
  • Coign Capital Advisors's Johnson & Johnson position peaked at $864K in Q4 2025.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Coign Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.